Price Target Changed • May 11
Price target increased by 10% to ₹211 Up from ₹191, the current price target is an average from 6 analysts. New target price is 15% above last closing price of ₹183. Stock is down 2.6% over the past year. The company is forecast to post earnings per share of ₹6.28 for next year compared to ₹3.33 last year. Declared Dividend • May 11
Dividend reduced to ₹1.50 Dividend of ₹1.50 is 25% lower than last year. Ex-date: 24th July 2026 Payment date: 2nd September 2026 Dividend yield will be 0.8%, which is about the same as the industry average. Sustainability & Growth Dividend is well covered by both earnings (32% earnings payout ratio) and cash flows (43% cash payout ratio). The dividend has increased by an average of 5.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 112% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Aankondiging • May 09
NOCIL Limited announces Annual dividend, payable on September 02, 2026 NOCIL Limited announced Annual dividend of INR 1.5000 per share payable on September 02, 2026, ex-date on July 24, 2026 and record date on July 24, 2026. Reported Earnings • May 09
Full year 2026 earnings released: EPS: ₹3.33 (vs ₹6.17 in FY 2025) Full year 2026 results: EPS: ₹3.33 (down from ₹6.17 in FY 2025). Revenue: ₹13.4b (down 3.8% from FY 2025). Net income: ₹556.3m (down 46% from FY 2025). Profit margin: 4.2% (down from 7.4% in FY 2025). Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Aankondiging • May 08
NOCIL Limited, Annual General Meeting, Aug 03, 2026 NOCIL Limited, Annual General Meeting, Aug 03, 2026, at 15:00 Indian Standard Time. Aankondiging • Apr 10
NOCIL Limited to Report Fiscal Year 2026 Results on May 07, 2026 NOCIL Limited announced that they will report fiscal year 2026 results at 12:08 PM, Indian Standard Time on May 07, 2026 Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹160, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 19% over the past three years. Price Target Changed • Feb 13
Price target increased by 7.5% to ₹214 Up from ₹199, the current price target is an average from 7 analysts. New target price is 42% above last closing price of ₹151. Stock is down 25% over the past year. The company is forecast to post earnings per share of ₹4.40 for next year compared to ₹6.17 last year. Aankondiging • Jan 19
NOCIL Limited to Report Q3, 2026 Results on Feb 11, 2026 NOCIL Limited announced that they will report Q3, 2026 results at 12:08 PM, Indian Standard Time on Feb 11, 2026 Buy Or Sell Opportunity • Nov 13
Now 22% overvalued after recent price rise Over the last 90 days, the stock has risen 2.2% to ₹178. The fair value is estimated to be ₹146, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 8.2% over the last 3 years. Earnings per share has declined by 24%. Revenue is forecast to grow by 24% in 2 years. Earnings are forecast to grow by 115% in the next 2 years. Reported Earnings • Nov 01
Second quarter 2026 earnings released: EPS: ₹0.73 (vs ₹2.53 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.73 (down from ₹2.53 in 2Q 2025). Revenue: ₹3.31b (down 11% from 2Q 2025). Net income: ₹121.2m (down 71% from 2Q 2025). Profit margin: 3.7% (down from 11% in 2Q 2025). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Aankondiging • Oct 06
NOCIL Limited to Report Q2, 2026 Results on Oct 31, 2025 NOCIL Limited announced that they will report Q2, 2026 results on Oct 31, 2025 Price Target Changed • Oct 06
Price target decreased by 7.8% to ₹202 Down from ₹219, the current price target is an average from 8 analysts. New target price is 12% above last closing price of ₹181. Stock is down 34% over the past year. The company is forecast to post earnings per share of ₹5.78 for next year compared to ₹6.17 last year. Upcoming Dividend • Jul 23
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 30 July 2025. Payment date: 06 September 2025. Payout ratio is a comfortable 32% but the company is not cash flow positive. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Aankondiging • Jul 16
NOCIL Limited to Report Q1, 2026 Results on Aug 07, 2025 NOCIL Limited announced that they will report Q1, 2026 results on Aug 07, 2025 Reported Earnings • Jul 15
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: ₹6.17 (down from ₹7.98 in FY 2024). Revenue: ₹13.9b (down 3.6% from FY 2024). Net income: ₹1.03b (down 23% from FY 2024). Profit margin: 7.4% (down from 9.2% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 4.7%. Revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings. Declared Dividend • May 21
Dividend reduced to ₹2.00 Dividend of ₹2.00 is 33% lower than last year. Ex-date: 30th July 2025 Payment date: 6th September 2025 Dividend yield will be 1.1%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (38% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 76% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Aankondiging • May 20
NOCIL Limited announces Annual dividend, payable on September 06, 2025 NOCIL Limited announced Annual dividend of INR 2.0000 per share payable on September 06, 2025, ex-date on July 30, 2025 and record date on July 30, 2025. Price Target Changed • May 20
Price target decreased by 7.3% to ₹221 Down from ₹238, the current price target is an average from 9 analysts. New target price is 23% above last closing price of ₹179. Stock is down 32% over the past year. The company is forecast to post earnings per share of ₹7.02 for next year compared to ₹6.17 last year. Aankondiging • May 16
NOCIL Limited, Annual General Meeting, Aug 07, 2025 NOCIL Limited, Annual General Meeting, Aug 07, 2025. Reported Earnings • May 16
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: ₹6.17 (down from ₹7.98 in FY 2024). Revenue: ₹14.2b (down 1.4% from FY 2024). Net income: ₹1.03b (down 23% from FY 2024). Profit margin: 7.2% (down from 9.2% in FY 2024). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 4.7%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Aankondiging • Apr 28
NOCIL Limited to Report Fiscal Year 2025 Results on May 15, 2025 NOCIL Limited announced that they will report fiscal year 2025 results on May 15, 2025 Price Target Changed • Feb 17
Price target decreased by 7.5% to ₹248 Down from ₹268, the current price target is an average from 9 analysts. New target price is 27% above last closing price of ₹195. Stock is down 33% over the past year. The company is forecast to post earnings per share of ₹6.50 for next year compared to ₹7.98 last year. Reported Earnings • Feb 07
Third quarter 2025 earnings released: EPS: ₹0.77 (vs ₹1.80 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.77 (down from ₹1.80 in 3Q 2024). Revenue: ₹3.27b (down 3.9% from 3Q 2024). Net income: ₹129.0m (down 57% from 3Q 2024). Profit margin: 3.9% (down from 8.8% in 3Q 2024). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Aankondiging • Jan 15
NOCIL Limited to Report Q3, 2025 Results on Feb 06, 2025 NOCIL Limited announced that they will report Q3, 2025 results on Feb 06, 2025 Reported Earnings • Oct 30
Second quarter 2025 earnings released: EPS: ₹2.53 (vs ₹1.63 in 2Q 2024) Second quarter 2025 results: EPS: ₹2.53 (up from ₹1.63 in 2Q 2024). Revenue: ₹3.71b (up 5.8% from 2Q 2024). Net income: ₹421.3m (up 55% from 2Q 2024). Profit margin: 11% (up from 7.7% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Aankondiging • Oct 09
NOCIL Limited to Report Q2, 2025 Results on Oct 28, 2024 NOCIL Limited announced that they will report Q2, 2025 results at 12:08 PM, Indian Standard Time on Oct 28, 2024 New Risk • Aug 12
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 0.3% per year for the foreseeable future. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Aankondiging • Aug 09
NOCIL Limited Approves Dividend Payment NOCIL Limited approved at its AGM held on 8 August 2024 the dividend of INR 3/- per equity shares of INR 10 /- each. Upcoming Dividend • Jul 19
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 26 July 2024. Payment date: 07 September 2024. Payout ratio is a comfortable 38% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%). Reported Earnings • Jul 13
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: EPS: ₹7.98 (down from ₹8.95 in FY 2023). Revenue: ₹14.4b (down 11% from FY 2023). Net income: ₹1.33b (down 11% from FY 2023). Profit margin: 9.2% (in line with FY 2023). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 5.3%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 4% per year. Board Change • Jul 13
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Ramesh Iyer was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Aankondiging • Jun 29
NOCIL Limited Announces Caseation of Directors NOCIL Limited announced that Mr. Rohit Arora (Mr. Pradeep V. Bhide (DIN:03304262) and Mr. Dhananjay Mungale (DIN:00007563) have ceased to be an Independent Director of the Company upon completion of their second term of 5 (five) consecutive years on 29th June, 2024 . Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹269, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 35% over the past three years. Reported Earnings • Jun 04
Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2024 results: EPS: ₹7.98 (down from ₹8.95 in FY 2023). Revenue: ₹14.4b (down 11% from FY 2023). Net income: ₹1.33b (down 11% from FY 2023). Profit margin: 9.2% (in line with FY 2023). Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) exceeded analyst estimates by 5.3%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 3% per year. Aankondiging • May 31
NOCIL Limited, Annual General Meeting, Aug 08, 2024 NOCIL Limited, Annual General Meeting, Aug 08, 2024. Declared Dividend • May 31
Dividend of ₹3.00 announced Dividend of ₹3.00 is the same as last year. Ex-date: 26th July 2024 Payment date: 7th September 2024 Dividend yield will be 1.2%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has increased by an average of 17% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 59% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Aankondiging • May 09
NOCIL Limited to Report Fiscal Year 2024 Results on May 29, 2024 NOCIL Limited announced that they will report fiscal year 2024 results on May 29, 2024 Price Target Changed • Feb 21
Price target increased by 7.6% to ₹268 Up from ₹249, the current price target is an average from 8 analysts. New target price is 5.1% below last closing price of ₹283. Stock is up 23% over the past year. The company is forecast to post earnings per share of ₹8.10 for next year compared to ₹8.95 last year. Reported Earnings • Feb 11
Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind Third quarter 2024 results: EPS: ₹1.80 (up from ₹1.12 in 3Q 2023). Revenue: ₹3.41b (up 4.6% from 3Q 2023). Net income: ₹300.0m (up 61% from 3Q 2023). Profit margin: 8.8% (up from 5.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 7.5%. Earnings per share (EPS) exceeded analyst estimates by 12%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jan 10
NOCIL Limited to Report Q3, 2024 Results on Feb 07, 2024 NOCIL Limited announced that they will report Q3, 2024 results on Feb 07, 2024 Price Target Changed • Nov 09
Price target decreased by 7.3% to ₹220 Down from ₹238, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of ₹225. Stock is up 2.3% over the past year. The company is forecast to post earnings per share of ₹7.50 for next year compared to ₹8.95 last year. Reported Earnings • Nov 03
Second quarter 2024 earnings released: EPS: ₹1.63 (vs ₹2.14 in 2Q 2023) Second quarter 2024 results: EPS: ₹1.63 (down from ₹2.14 in 2Q 2023). Revenue: ₹3.56b (down 8.7% from 2Q 2023). Net income: ₹271.6m (down 24% from 2Q 2023). Profit margin: 7.6% (down from 9.2% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 16% per year. Aankondiging • Oct 10
NOCIL Limited to Report Q2, 2024 Results on Nov 02, 2023 NOCIL Limited announced that they will report Q2, 2024 results on Nov 02, 2023 New Risk • Aug 01
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 7.8% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (7.8% net profit margin). Upcoming Dividend • Jul 17
Upcoming dividend of ₹3.00 per share at 1.4% yield Eligible shareholders must have bought the stock before 24 July 2023. Payment date: 30 August 2023. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 1.4%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%). Aankondiging • Jul 12
NOCIL Limited to Report Q1, 2024 Results on Jul 31, 2023 NOCIL Limited announced that they will report Q1, 2024 results on Jul 31, 2023 Reported Earnings • Jul 08
Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat Full year 2023 results: EPS: ₹8.95 (down from ₹10.58 in FY 2022). Revenue: ₹16.2b (up 2.9% from FY 2022). Net income: ₹1.49b (down 15% from FY 2022). Profit margin: 9.2% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.8%. Earnings per share (EPS) were mostly in line with analyst estimates. Revenue is forecast to grow 9.0% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 27% per year. Price Target Changed • Jun 01
Price target decreased by 9.0% to ₹221 Down from ₹243, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of ₹225. Stock is down 11% over the past year. The company is forecast to post earnings per share of ₹9.70 for next year compared to ₹8.95 last year. Reported Earnings • May 30
Full year 2023 earnings: EPS misses analyst expectations Full year 2023 results: EPS: ₹8.95 (down from ₹10.58 in FY 2022). Revenue: ₹16.2b (up 3.3% from FY 2022). Net income: ₹1.49b (down 15% from FY 2022). Profit margin: 9.2% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.0%. Revenue is forecast to grow 9.7% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • May 13
NOCIL Limited to Report Fiscal Year 2023 Results on May 29, 2023 NOCIL Limited announced that they will report fiscal year 2023 results on May 29, 2023 Price Target Changed • Mar 10
Price target decreased by 11% to ₹243 Down from ₹273, the current price target is an average from 4 analysts. New target price is 8.7% above last closing price of ₹223. Stock is up 9.0% over the past year. The company is forecast to post earnings per share of ₹9.60 for next year compared to ₹10.58 last year. Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹1.12 (vs ₹1.79 in 3Q 2022) Third quarter 2023 results: EPS: ₹1.12 (down from ₹1.79 in 3Q 2022). Revenue: ₹3.28b (down 16% from 3Q 2022). Net income: ₹186.2m (down 38% from 3Q 2022). Profit margin: 5.7% (down from 7.7% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Jan 17
NOCIL Limited to Report Q3, 2023 Results on Feb 10, 2023 NOCIL Limited announced that they will report Q3, 2023 results at 4:00 PM, Indian Standard Time on Feb 10, 2023 Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 7 highly experienced directors. Deputy MD & Executive Director V. Anand was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 10
Second quarter 2023 earnings released: EPS: ₹2.14 (vs ₹1.80 in 2Q 2022) Second quarter 2023 results: EPS: ₹2.14 (up from ₹1.80 in 2Q 2022). Revenue: ₹3.90b (up 4.0% from 2Q 2022). Net income: ₹357.3m (up 19% from 2Q 2022). Profit margin: 9.2% (up from 8.0% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Aankondiging • Oct 12
NOCIL Limited to Report First Half, 2023 Results on Nov 08, 2022 NOCIL Limited announced that they will report first half, 2023 results on Nov 08, 2022 Upcoming Dividend • Jul 13
Upcoming dividend of ₹3.00 per share Eligible shareholders must have bought the stock before 20 July 2022. Payment date: 27 August 2022. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.8%). Higher than average of industry peers (0.8%). Reported Earnings • Jul 05
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: ₹10.58 (up from ₹5.33 in FY 2021). Revenue: ₹15.7b (up 70% from FY 2021). Net income: ₹1.76b (up 99% from FY 2021). Profit margin: 11% (up from 9.6% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Over the next year, revenue is forecast to grow 18%, compared to a 17% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings. Aankondiging • Jul 04
NOCIL Limited to Report Q1, 2023 Results on Jul 28, 2022 NOCIL Limited announced that they will report Q1, 2023 results on Jul 28, 2022 Board Change • Jun 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 6 highly experienced directors. Deputy MD & Additional Director V. Anand was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Major Estimate Revision • May 24
Consensus EPS estimates increase by 11% The consensus outlook for earnings per share (EPS) in 2023 has improved. 2023 revenue forecast increased from ₹17.6b to ₹18.5b. EPS estimate increased from ₹12.65 to ₹14.10 per share. Net income forecast to grow 33% next year vs 24% growth forecast for Chemicals industry in India. Consensus price target broadly unchanged at ₹304. Share price rose 4.2% to ₹254 over the past week. Reported Earnings • May 19
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: EPS: ₹10.58 (up from ₹5.33 in FY 2021). Revenue: ₹15.7b (up 70% from FY 2021). Net income: ₹1.76b (up 99% from FY 2021). Profit margin: 11% (up from 9.6% in FY 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.4%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Over the next year, revenue is forecast to grow 12%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings. Aankondiging • May 07
NOCIL Limited to Report Fiscal Year 2022 Results on May 17, 2022 NOCIL Limited announced that they will report fiscal year 2022 results on May 17, 2022 Aankondiging • Apr 19
Nocil Limited Announces Demise of Mr. N. Sankar, Independent Director NOCIL Limited announced sudden and sad demise of Mr. N. Sankar, Independent Director of the company on Sunday, 17 April,2022. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improved over the past week After last week's 15% share price gain to ₹250, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 90% over the past three years. Buying Opportunity • Feb 24
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 17%. The fair value is estimated to be ₹248, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 12% per annum over the last 3 years. Earnings per share has declined by 17% per annum over the last 3 years. Major Estimate Revision • Feb 11
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from ₹14.9b to ₹15.1b. EPS estimate fell from ₹10.60 to ₹9.10 per share. Net income forecast to grow 45% next year vs 21% growth forecast for Chemicals industry in India. Consensus price target down from ₹340 to ₹301. Share price fell 3.7% to ₹221 over the past week. Price Target Changed • Feb 08
Price target decreased to ₹301 Down from ₹340, the current price target is provided by 1 analyst. New target price is 35% above last closing price of ₹223. Stock is up 46% over the past year. The company is forecast to post earnings per share of ₹9.10 for next year compared to ₹5.33 last year. Aankondiging • Feb 05
NOCIL Limited Announces Appointment of Anand V.S. as Deputy Managing Director, with Effect from March 3, 2022 NOCIL Limited informed that based on recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company, at its meeting held on 4th February,2022 has appointed Mr. Anand V.S. as Additional Director designated as Deputy Managing Director of the Company w.e.f. 3rd March, 2022. The aforementioned appointment shall be subject to the approval of the Members by way of a Postal Ballot. Appointment for a period of 5 (five) years from 3rd March, 2022 to 2nd March, 2027 subject to the approval of the Members by way of a Postal Ballot. Prior to joining NOCIL, Mr. Anand was Managing Director of Chemetall India (BASF Company). Mr. Anand was associated with BASF from 1997 till February 2022. He has over two decades of diverse experience across Textile Chemicals, Care Chemicals etc. During his career he has led various leadership role. Reported Earnings • Feb 05
Third quarter 2022 earnings: EPS exceeds analyst expectations Third quarter 2022 results: EPS: ₹1.79 (up from ₹1.34 in 3Q 2021). Revenue: ₹3.89b (up 42% from 3Q 2021). Net income: ₹297.9m (up 34% from 3Q 2021). Profit margin: 7.7% (down from 8.1% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 19%, compared to a 21% growth forecast for the industry in India. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Reported Earnings • Nov 06
Second quarter 2022 earnings released: EPS ₹1.80 (vs ₹1.02 in 2Q 2021) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹3.77b (up 70% from 2Q 2021). Net income: ₹299.9m (up 78% from 2Q 2021). Profit margin: 8.0% (up from 7.6% in 2Q 2021). The increase in margin was driven by higher revenue. Recent Insider Transactions • Sep 01
Insider recently sold ₹1.4m worth of stock On the 27th of August, C. Nandi sold around 5k shares on-market at roughly ₹277 per share. In the last 3 months, they made an even bigger sale worth ₹8.2m. Insiders have been net sellers, collectively disposing of ₹229m more than they bought in the last 12 months. Recent Insider Transactions • Aug 12
Insider recently sold ₹2.8m worth of stock On the 6th of August, C. Nandi sold around 10k shares on-market at roughly ₹290 per share. In the last 3 months, they made an even bigger sale worth ₹8.2m. Insiders have been net sellers, collectively disposing of ₹227m more than they bought in the last 12 months. Major Estimate Revision • Aug 10
Consensus revenue estimates increase to ₹13.2b The consensus outlook for revenues in 2022 has improved. 2022 revenue forecast increased from ₹11.8b to ₹13.2b. EPS estimate increased from ₹8.25 to ₹10.60 per share. Net income forecast to grow 48% next year vs 17% growth forecast for Chemicals industry in India. Consensus price target up from ₹246 to ₹321. Share price fell 5.6% to ₹267 over the past week. Upcoming Dividend • Jul 19
Upcoming dividend of ₹2.00 per share Eligible shareholders must have bought the stock before 26 July 2021. Payment date: 02 September 2021. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.4%). In line with average of industry peers (0.7%). Reported Earnings • Jul 11
Full year 2021 earnings released: EPS ₹5.33 (vs ₹7.89 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹9.25b (up 9.3% from FY 2020). Net income: ₹884.1m (down 32% from FY 2020). Profit margin: 9.6% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 17% share price gain to ₹254, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at ₹136 per share. Recent Insider Transactions • Jun 23
Insider recently sold ₹2.1m worth of stock On the 17th of June, C. Nandi sold around 10k shares on-market at roughly ₹212 per share. In the last 3 months, they made an even bigger sale worth ₹8.2m. Insiders have been net sellers, collectively disposing of ₹217m more than they bought in the last 12 months. Recent Insider Transactions • Jun 16
Vice President of QA recently sold ₹2.1m worth of stock On the 10th of June, N. Gangal sold around 10k shares on-market at roughly ₹210 per share. In the last 3 months, there was an even bigger sale from another insider worth ₹8.2m. Insiders have been net sellers, collectively disposing of ₹215m more than they bought in the last 12 months. Recent Insider Transactions • Jun 05
Insider recently sold ₹8.2m worth of stock On the 3rd of June, C. Nandi sold around 40k shares on-market at roughly ₹204 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹213m more than they bought in the last 12 months. Reported Earnings • May 30
Full year 2021 earnings released: EPS ₹5.33 (vs ₹7.89 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: ₹9.39b (up 11% from FY 2020). Net income: ₹884.1m (down 32% from FY 2020). Profit margin: 9.4% (down from 15% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Aankondiging • May 28
NOCIL Limited Announces Final Dividend NOCIL Limited announced that its board of directors, at the Meeting held on May 27, 2021, has declared an final Dividend of INR 2.00 per Equity Share of the face value of INR 10 each (20% of the face value) which is subject to approval by the Members of the Company at the Annual General Meeting to be held on 3 August, 2021. Recent Insider Transactions • Apr 02
Vice President of QA recently sold ₹2.9m worth of stock On the 26th of March, N. Gangal sold around 17k shares on-market at roughly ₹176 per share. In the last 3 months, there was an even bigger sale from another insider worth ₹12m. Insiders have been net sellers, collectively disposing of ₹191m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improved over the past week After last week's 17% share price gain to ₹175, the stock is trading at a trailing P/E ratio of 39.6x, up from the previous P/E ratio of 33.8x. This compares to an average P/E of 17x in the Chemicals industry in India. Total returns to shareholders over the past three years are 2.6%. Recent Insider Transactions • Feb 12
Vice President of QA recently sold ₹4.6m worth of stock On the 8th of February, N. Gangal sold around 30k shares on-market at roughly ₹154 per share. In the last 3 months, there was an even bigger sale from another insider worth ₹13m. Insiders have been net sellers, collectively disposing of ₹161m more than they bought in the last 12 months. Is New 90 Day High Low • Feb 12
New 90-day high: ₹161 The company is up 9.0% from its price of ₹147 on 14 November 2020. The Indian market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is ₹118 per share. Major Estimate Revision • Feb 09
Analysts increase revenue estimates to ₹9.21b The 2021 consensus revenue estimate increased from ₹8.04b. Earning per share (EPS) estimate also increased from ₹4.60 to ₹5.15 for the same period. Net income is expected to grow by 63% next year compared to 27% growth forecast for the Chemicals industry in India. The consensus price target increased from ₹148 to ₹174. Share price is up 6.7% to ₹152 over the past week. Price Target Changed • Feb 04
Price target raised to ₹157 Up from ₹140, the current price target is an average from 2 analysts. The new target price is close to the current share price of ₹152. As of last close, the stock is up 54% over the past year. Reported Earnings • Feb 03
Third quarter 2021 earnings released: EPS ₹1.34 (vs ₹1.27 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: ₹2.75b (up 41% from 3Q 2020). Net income: ₹223.1m (up 6.3% from 3Q 2020). Profit margin: 8.1% (down from 11% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.